Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants
NCT00753649
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
224
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis B
Tetanus
Poliomyelitis
Diphtheria
Haemophilus Influenzae Type b
Acellular Pertussis
Interventions
BIOLOGICAL:
Infanrix™ hexa
Sponsor
GlaxoSmithKline